BenzingaOctober 9, 2026 at 4:22 AM NY18 Days Ago
Morgan Stanley Maintains Overweight on CME Group, Raises Price Target to $337
Morgan Stanley analyst Michael Cyprys maintains CME Group (NASDAQ:CME) with a Overweight and raises the price target from $330 to $337.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
